Seractil® (Dexibuprofen) Pharmacology and Nursing Considerations

Flashcards covering the classification, active ingredient, therapeutic actions, adverse reactions, and nursing care considerations for Seractil® (Dexibuprofen).

Seractil®

An orally administered non-steroidal anti-inflammatory drug (NSAR) classified as a WHO Step 1 analgesic.

Dexibuprofen

The active pharmaceutical ingredient (Wirkstoff) of Seractil®.

Analgesic effect (analgetisch)

The pain-relieving therapeutic effect provided by Seractil®.

Antiphlogistic effect (antiphlogistisch)

The anti-inflammatory (entzündungshemmend) action exerted by Seractil®.

Antipyretic effect (antipyretisch)

The fever-reducing (fiebersenkend) therapeutic property of Seractil®.

Magenschädigung (Gastric mucosal damage)

An adverse side effect of Seractil® manifested as erosion and bleeding of the gastric mucosa (Erosion und Blutung der Magenschleimhaut).

Vertigo

A side effect of Seractil® presenting as dizziness, which necessitates fall prevention precautions (Sturzprophylaxe).

Teerstuhl (Tarry stool)

Black stool or blood in stool indicating potential gastrointestinal bleeding, which must be closely monitored during Seractil® treatment.

Proton pump inhibitor (Protonenpumpenhemmer)

A physician-ordered medication whose correct intake must be verified by nursing staff to protect against gastrointestinal mucosal damage.

Post-meal administration (nach den Mahlzeiten verabreichen)

The recommended timing for administering Seractil® to help minimize gastrointestinal side effects.

Nierenfunktionsstörungen (Renal dysfunction)

An adverse effect of Seractil® requiring regular observation of renal function and the active promotion of adequate fluid intake.

Sturzprophylaxe (Fall prevention)

A specific nursing care measure implemented to protect patients experiencing vertigo from Seractil®.